IperionX enters September with a curious split: the stock is edging higher, but short sellers are quietly adding to what is already a heavy bearish position.
Short interest is the dominant story here. Bears hold 10.8% of the free float — a level firmly in elevated territory — and that position has grown steadily, up 4.3% over the past week and 5.2% over the past month. The ORTEX short score has climbed to 82.3, its highest reading in recent weeks, and has risen every session since August 19. What makes the build more meaningful is the tightening in the lending pool: availability dropped sharply to 61.2% from 72% just two days earlier, its tightest level in the past year — the 52-week floor was 53.8%. Earlier in August, availability was running above 95%, so the move is sudden. Cost to borrow, at 3.6%, is up 6% on the week. The picture is one of growing short conviction meeting a lending market that is starting to feel the strain.
Yet the stock is not behaving like one under pressure. IPX closed Tuesday at AUD 3.10, up 4% on the day and 1.6% on the week. Most of the peer group moved in the opposite direction: CHN fell 9% on the week, CMM dropped 5.8%, and shed 5.7%. Only — up 15.5% — and — up 4.1% — kept pace. IPX is outperforming a broadly weak materials peer basket despite the bearish positioning building underneath it.
Institutional ownership helps explain why short sellers may be fighting an uphill battle. BNY Asset Management holds 26.7% of shares, a dominant anchor position that was expanded by nearly 25 million shares in the most recent reported period. State Street added 5 million shares as recently as mid-August. JPMorgan's custodial position also grew by 4.2 million shares in early August. The register is concentrated and, outside a few trim positions, largely directional — which limits the free float that shorts can work with and contributes to the tightening availability.
On the fundamental side, the ORTEX combined stock score of 82.5 reflects the short pressure, but the underlying quality and value scores remain weak. The company carries a deeply negative return on assets of -29% and a price-to-book ratio above 12, which leaves the EV/equity valuation difficult to justify on near-term fundamentals alone. The investment case rests squarely on the critical minerals theme — domestic titanium and rare earth processing for defence and aerospace — rather than current profitability. The mean analyst price target of AUD 5.15, though the most recent change is more than a month old, implies meaningful upside to the current price, suggesting the Street has not abandoned the long-term thesis even as operational metrics remain stretched.
Insider buying adds another layer of complexity. Both the Executive Chairman, Todd Hannigan, and CEO Anastasios Arima have been persistent buyers across multiple tranches in 2026, most recently in mid-July at prices around AUD 3.58. Combined, those July purchases represent close to AUD 1.6 million of personal capital deployed close to where the stock trades today — a signal that leadership views current levels as an opportunity rather than a ceiling.
Earnings are due September 24. The prior four reports produced moves of +13%, -16%, +8%, and -26% on the following day — a pattern of high-volatility, binary reactions that gives both bulls and bears reason to stay positioned. With availability tightening and the short score still climbing heading into that event, the tension between a heavily shorted register and a concentrated institutional long base is the dynamic worth tracking most closely into the print.
See the live data behind this article on ORTEX.
Open IPX on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
